Goldman Sachs’s Capricor Therapeutics CAPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$715K Sell
71,971
-339,170
-82% -$3.37M ﹤0.01% 4053
2025
Q1
$3.9M Buy
411,141
+116,373
+39% +$1.1M ﹤0.01% 2924
2024
Q4
$4.07M Buy
294,768
+216,504
+277% +$2.99M ﹤0.01% 3010
2024
Q3
$1.19M Sell
78,264
-4,432
-5% -$67.4K ﹤0.01% 3665
2024
Q2
$394K Sell
82,696
-130,473
-61% -$622K ﹤0.01% 4072
2024
Q1
$1.45M Buy
213,169
+197,929
+1,299% +$1.34M ﹤0.01% 3387
2023
Q4
$74.5K Sell
15,240
-9,309
-38% -$45.5K ﹤0.01% 4504
2023
Q3
$84K Hold
24,549
﹤0.01% 4414
2023
Q2
$117K Sell
24,549
-75
-0.3% -$358 ﹤0.01% 4539
2023
Q1
$104K Buy
24,624
+30
+0.1% +$127 ﹤0.01% 4670
2022
Q4
$94.9K Sell
24,594
-370
-1% -$1.43K ﹤0.01% 4685
2022
Q3
$150K Buy
24,964
+15
+0.1% +$90 ﹤0.01% 4811
2022
Q2
$87K Sell
24,949
-17,289
-41% -$60.3K ﹤0.01% 5158
2022
Q1
$145K Buy
42,238
+11,821
+39% +$40.6K ﹤0.01% 5196
2021
Q4
$89K Buy
30,417
+8,279
+37% +$24.2K ﹤0.01% 5255
2021
Q3
$89K Buy
+22,138
New +$89K ﹤0.01% 5077
2020
Q3
Sell
-38,808
Closed -$179K 4437
2020
Q2
$179K Buy
+38,808
New +$179K ﹤0.01% 4018
2017
Q3
Sell
-4,082
Closed -$34K 4280
2017
Q2
$34K Sell
4,082
-1,697
-29% -$14.1K ﹤0.01% 4288
2017
Q1
$195K Sell
5,779
-1,777
-24% -$60K ﹤0.01% 3963
2016
Q4
$201K Sell
7,556
-2,529
-25% -$67.3K ﹤0.01% 3884
2016
Q3
$327K Sell
10,085
-475
-4% -$15.4K ﹤0.01% 3662
2016
Q2
$417K Sell
10,560
-236
-2% -$9.32K ﹤0.01% 3433
2016
Q1
$274K Sell
10,796
-478
-4% -$12.1K ﹤0.01% 3601
2015
Q4
$347K Sell
11,274
-2,494
-18% -$76.8K ﹤0.01% 3438
2015
Q3
$558K Buy
13,768
+7,342
+114% +$298K ﹤0.01% 3234
2015
Q2
$325K Buy
+6,426
New +$325K ﹤0.01% 3656